161 related articles for article (PubMed ID: 16440417)
21. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
[TBL] [Abstract][Full Text] [Related]
22. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
23. The clinicopathological significance of micropapillary pattern in colorectal cancers.
Pyo JS; Park MJ; Kang DW
Hum Pathol; 2018 Jul; 77():159-165. PubMed ID: 29634975
[TBL] [Abstract][Full Text] [Related]
24. Involvement of galectin-3 expression in colorectal cancer progression and metastasis.
Nakamura M; Inufusa H; Adachi T; Aga M; Kurimoto M; Nakatani Y; Wakano T; Nakajima A; Hida JI; Miyake M; Shindo K; Yasutomi M
Int J Oncol; 1999 Jul; 15(1):143-8. PubMed ID: 10375607
[TBL] [Abstract][Full Text] [Related]
25. Expression of MUC5AC in colorectal carcinoma and relationship with prognosis.
Kocer B; Soran A; Erdogan S; Karabeyoglu M; Yildirim O; Eroglu A; Bozkurt B; Cengiz O
Pathol Int; 2002 Jul; 52(7):470-7. PubMed ID: 12167106
[TBL] [Abstract][Full Text] [Related]
26. Expression of interleukin-11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors.
Yamazumi K; Nakayama T; Kusaba T; Wen CY; Yoshizaki A; Yakata Y; Nagayasu T; Sekine I
World J Gastroenterol; 2006 Jan; 12(2):317-21. PubMed ID: 16482637
[TBL] [Abstract][Full Text] [Related]
27. [Histological localization of mucin core polypeptide MUC-2 in application to the differential diagnosis of adenocarcinoma].
Yuan M
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):139-41. PubMed ID: 1477935
[TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
29. Tissue factor expression and metastatic potential of colorectal cancer.
Shigemori C; Wada H; Matsumoto K; Shiku H; Nakamura S; Suzuki H
Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
[TBL] [Abstract][Full Text] [Related]
30. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
31. A study on the correlations of MRP-1 expression with the pathogenesis and prognosis of colorectal cancer.
Yang J; Song P; Zhou G
J BUON; 2019; 24(1):84-90. PubMed ID: 30941955
[TBL] [Abstract][Full Text] [Related]
32. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
33. Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma.
Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 1994; 51(3):228-33. PubMed ID: 7515172
[TBL] [Abstract][Full Text] [Related]
34. Expression of Fas ligand is an early event in colorectal carcinogenesis.
Shimoyama M; Kanda T; Liu L; Koyama Y; Suda T; Sakai Y; Hatakeyama K
J Surg Oncol; 2001 Jan; 76(1):63-8; discussion 69. PubMed ID: 11223827
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.
Hiraki T; Yamada S; Higashi M; Hatanaka K; Yokoyama S; Kitazono I; Goto Y; Kirishima M; Batra SK; Yonezawa S; Tanimoto A
Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051
[TBL] [Abstract][Full Text] [Related]
36. Predictors of lymph node metastasis in T1 colorectal carcinoma: an immunophenotypic analysis of 265 patients.
Nishida T; Egashira Y; Akutagawa H; Fujii M; Uchiyama K; Shibayama Y; Hirose Y
Dis Colon Rectum; 2014 Aug; 57(8):905-15. PubMed ID: 25003285
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
[TBL] [Abstract][Full Text] [Related]
38. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
